The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children… (NCT02998502) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
United States73 participantsStarted 2026-08-01
Plain-language summary
This study will test the efficiency of the Freespira Breathing System in youth.
Who can participate
Age range9 Years – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* SCARED score ≥ 25 + prior clinical diagnosis of an anxiety disorder
* Participants must be 9-17 years of age
* If on psychotropic medication(s), participant must be on a stable dose for at least one month prior to study enrollment
Exclusion Criteria:
* Anxiety has occurred exclusively during a major depressive episode, psychiatric illness, dementia, intellectual disability, or brain disease
* Currently enrolled in another device or drug study or less than 30 days has elapsed since participation in such a study
* Currently undergoing breathing biofeedback elsewhere
* Demonstrate evidence of severe suicidal ideation or psychosis
* There is an active condition of asthma
What they're measuring
1
Screen for Child Anxiety Related Disorders (SCARED) scale score